The ability of different biological therapies to reduce the use of systemic steroids and the rate of asthma exacerbations in severe asthma: experience from a single center
Objective Biological therapies are used to treat patients with severe asthma (SA) with type 2 inflammation. These biologics have been shown to reduce oral corticosteroids and asthma exacerbations and improve patients’ quality of life. This study will examine the extent to which biological therapies...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Ráidu: | Egyptian Journal of Chest Disease and Tuberculosis |
| Fáttát: | |
| Liŋkkat: | http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2021;volume=70;issue=4;spage=447;epage=454;aulast=Eldaabossi |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|